Parmax Pharma Performance
- Today's Low
- ₹101
- Today's High
- ₹105
- 52 Week Low
- ₹23
- 52 Week High
- ₹109
- Open Price₹101
- Previous Close₹103
- Volume106,657
- 50 DMA₹73.50
- 100 DMA₹58.30
- 200 DMA₹48.00
Parmax Pharma Chart
Investment Returns
- Over 1 Month + 39.69%
- Over 3 Month + 227.95%
- Over 6 Month + 223.2%
- Over 1 Year + 174.34%
Smart Investing Starts Here Start SIP with Parmax Pharma for Steady Growth!
Parmax Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -9.4
- PEG Ratio
- 0.1
- Market Cap Cr
- 39
- P/B Ratio
- -5.7
- Average True Range
- 2.2
- EPS
- -11.1
- Dividend Yield
- 0
- MACD Signal
- 10.9
- RSI
- 81.84
- MFI
- 75
Latest Stock News Updates
Fedex Securities Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Letter of Offer for the attention of the Public Shareholders of Parmax Pharma Ltd ("Target Company").
- BSE India
- 4 days 22 hours ago
Compliance Certificate for quarter ended June 30, 2026
- BSE India
- 1 week 3 days ago
Scrutinizer report along with result of Evoting
- BSE India
- 3 weeks 2 days ago
Parmax Pharma Financials
Parmax Pharma Technicals
EMA & SMA
- Bearish Moving Average 0
- Bullish Moving Average 16
- 20 Day
- ₹92.30
- 50 Day
- ₹73.50
- 100 Day
- ₹58.30
- 200 Day
- ₹48.00
Resistance and Support
- R3 102.80
- R2 102.80
- R1 102.80
- S1 102.80
- S2 102.80
- S3 102.80
Parmax Pharma Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-06-08 | Fund raising | |
| 2026-06-02 | Audited Results | (Revised) |
| 2026-02-14 | Quarterly Results | |
| 2025-11-14 | Quarterly Results | |
| 2025-08-14 | Quarterly Results |
About Parmax Pharma
Parmax Pharma is engaged in the manufacture and supply of bulk drugs (APIs) and selected formulations catering primarily to the Indian pharmaceutical industry. View More- NSE Symbol
- PARMAX
- BSE Symbol
- 540359
- ISIN
- INE240T01014
Similar Stocks to Parmax Pharma
Popular Stocks
Parmax Pharma FAQs
Parmax Pharma share price is ₹104 As on 27 July, 2026 | 11:35
The Market Cap of Parmax Pharma is ₹39.2 Cr As on 27 July, 2026 | 11:35
The P/E ratio of Parmax Pharma is -9.4 As on 27 July, 2026 | 11:35
The PB ratio of Parmax Pharma is -5.7 As on 27 July, 2026 | 11:35
The 52 week High & Low of Parmax Pharma is ₹109.2/₹22.6 respectively As on 27 July, 2026 | 11:35
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.